The AVITA Medical (ASX: AVH) share price is up more than 7.5% this morning after making an announcement.
AVITA Medical is a regenerative medicine company with a technology platform to address unmet medical needs in burns, chronic wounds and aesthetics indications. Treatment solutions are derived from the regenerative properties of a patient’s own skin.
AVITA Medical’s Index News
The healthcare company announced that it will be added to the S&P / ASX 200 Index effective on market open on 14 November 2019 two months after being added to the S&P / ASX 300 index.
The S&P / ASX 200 is recognised as the institutional investable benchmark in Australia according to AVITA and the benchmark measures the performance of the largest 200 companies based on float-adjusted market capitalisation on the Australian Stock Exchange.
AVITA Medical CEO Dr Mike Perry said: “AVITA Medica’s inclusion in the S&P / ASX 200 index is a testament to the company’s solid growth trajectory following our US commercialisation of the RECELL System combined with the strength of our de-risked pipeline of future indications beyond burns.”
[ls_content_block id=”14946″ para=”paragraphs”]
[ls_content_block id=”18380″ para=”paragraphs”]
